Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: A case-control study

Journal of Affective Disorders

Volumn 122, Issue 1-2, 2010, Pages 174-178

  Maina, Giuseppe ^a   Rosso, Gianluca ^a   Zanardini, Roberta ^b   Bogetto, Filippo ^a   Gennarelli, Massimo ^b,c   Bocchio Chiavetto, Luisella ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

BDNF; Brain derived neurotrophic factor; Drug na ve; Obsessive compulsive disorder; OCD; Serum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DISTRESS SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; REFERENCE VALUES;

EID: 77649182475     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.07.009     Document Type: Article

References (29)

1. Alonso P., Gratacòs M., Menchón J., Saiz-Ruiz J., Segalàs C., Baca-García E., Labad J., Fernández-Piqueras J., Real E., Vaquero C., Pérez M., Dolengevich H., González J.R., Bayés M., de Cid R., Vallejo J., and Estivill X. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Biol. Psychiatry 63 (2008) 619-628
2. Bocchio-Chiavetto L., Zanardini R., Bortolomasi M., Abate M., Segala M., Giacopuzzi M., Riva M.A., Marchina E., Pasqualetti P., Perez J., and Gennarelli M. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur. Neuropsychopharmacol. 16 (2006) 620-624
3. Brunoni A.R., Lopes M., and Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11 (2008) 1169-1180
4. Carola V., Frazzetto G., Pascucci T., Audero E., Puglisi-Allegra S., Cabib S., Lesch K.P., and Gross C. Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol. Psychiatry 63 (2008) 840-846
5. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., and Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314 (2006) 140-143
6. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 (2006) 1116-1127
7. Fineberg N.A., Saxena S., Zohar J., and Craig K.J. Obsessive-compulsive disorder: boundary issues. CNS Spectr. 12 (2007) 359-364
8. First M.B., Spitzer R.L., and Gibbon M. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition, Version 2.0 (SCID-I/P) (1996), New York State Psychiatric Institute, Biometrics Research, New York
9. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., and Benjamin L.S. Structured Clinical Interview for DSM-IV Disorders Axis II (SCID-II) (1997), American Psychiatric Press, Washington, DC
10. Goodman W.K., and Lydiard R.B. Recognition and treatment of obsessive-compulsive disorder. J. Clin. Psychiatry 68 (2007) e30
11. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., and Charney D.S. The Yale-Brown Obsessive-Compulsive Scale, I: development, use and reliability. Arch. Gen. Psychiatry 46 (1989) 1006-1011
12. Grisham J.R., Anderson T.M., and Sachdev P.S. Genetic and environmental influences on obsessive-compulsive disorder. Eur. Arch. Psychiatry Clin. Neurosci. 258 (2008) 107-116
13. Hall D., Dhilla A., Charalambous A., Gogos J.A., and Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am. J. Hum. Genet. 73 (2003) 370-376
14. Hettema J.M., Neale M.C., and Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158 (2001) 1568-1578
15. Huang E.J., and Reichardt L.F. Neurotrophins. Roles in neuronal development and function. Annu. Rev. Neurosci. 24 (2001) 677-736
16. Lang U.E., Hellweg R., and Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29 (2004) 795-798
17. Lang U.E., Hellweg R., Sander T., and Gallinat J. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol. Psychiatry 14 (2009) 120-122
18. Maina G., Albert U., Salvi V., and Bogetto F. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison of serotonin reuptake inhibitors. J. Clin. Psychiatry 65 (2004) 1365-1371
19. Maina G., Albert U., Salvi V., Pessina E., and Bogetto F. Early-onset obsessive-compulsive disorder and personality disorders in adulthood. Psychiatry Res. 158 (2008) 217-225
20. Monteleone P., Fabrazzo M., Martiadis V., Serritella C., Pannuto M., and Maj M. Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables. Psychol. Med. 35 (2005) 897-905
21. Paykel E.S., Prusoff B.A., and Unlenhuth E.H. Scaling of life events. Arch. Gen. Psychiatry 25 (1971) 340
22. Racagni G., and Popoli M. Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin. Neurosci. 10 (2008) 385-400
23. Rasmussen S.A., and Eisen J.L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J. Clin. Psychiatry 55 (1994) 5-10
24. Saito S., Watanabe K., Hashimoto E., and Saito T. Low serum BDNF and food intake regulation: a possible new explanation of the pathophysiology of eating disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009) 312-316
25. Sen S., Duman R., and Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 64 (2008) 527-532
26. Ware J.E., and Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med. Care 30 (1992) 473-483
27. Wendland J.R., Kruse M.R., and Cromer K.R. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology 33 (2008) 1476
28. Yoshimura R., Kaneko S., Shinkai K., and Nakamura J. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamina: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels. Psychiatry Clin. Neurosci. 60 (2006) 389-393
29. Zanardini R., Gazzoli A., Ventriglia M., Perez J., Bignotti S., Rossini P.M., Gennarelli M., and Bocchio-Chiavetto L. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J. Affect. Disord. 91 (2006) 83-86